cGxP.wire https://validator.w3.org/feed/docs/rss2.html Arcturus to Present ARCT-810 Phase 2 OTC Deficiency Data AbbVie Wins EU Approval for RINVOQ in Pediatric JIA Otsuka Reports Phase 3b SIMTRIYO Data in ADHD and Anxiety PureTech Gains FDA Fast Track for LYT-200 in HR-MDS BoomRay, Novartis Sign Global License Deal for RLT Asset Opterion Health Advances OPT101 to Phase 2a After Phase 1 Akeso to Present Ivonescimab Phase 3 Data at ESMO 2026 AbbVie and Iambic Expand AI Drug Discovery Collaboration Smith+Nephew Showcases Shoulder Technologies at ICSES 2026 Johnson & Johnson Wins EU Approval for ICOTYDE in Psoriasis Moderna to Present Intismeran Data at ESMO 2026 Q32 Bio to Present Bempikibart Data at EADV 2026 Alkermes Reports Positive Phase 1b ADHD Data for ALKS 7290 NewAmsterdam Pharma Wins EU Approval for Ubeslo and Evlarco Cue Biopharma Reports Positive Phase 2 CUE-221 Results Tiziana Completes INFORM-MS Phase 2a Trial of Intranasal Foralumab Beacon Therapeutics Reports Positive VISTA Data for Laru-zova Merck Gains Positive EU CHMP Opinion for KEYTRUDA and Padcev Abeona Congratulates Ultragenyx on FAYUVI FDA Approval Co-Diagnostics Highlights Ebola Testing and Outbreak Innovation Sensorium Reports Positive Phase 1a Data for SNTX-2643 Natera Reports Largest Lung Cancer MRD Study for Signatera Quest Diagnostics Finds High Tick-Borne Disease Co-Exposure IMPACT Therapeutics Gains Positive CHMP Opinion for Senaparib Nabsys Advances CRISPR Genome Mapping With New Study Johnson & Johnson Reports Positive CAPLYTA Phase 3 Mania Data Alfasigma Gains Positive CHMP Opinion for Filgotinib in axSpA Veeva Launches Falcon Router for AI Safety Reporting Merck Launches Your Hive of Whole Health for HIV Care Precigen Gains FDA Platform Designation for AdenoVerse Zealand Pharma Gains Positive CHMP Opinion for Zeydovio Puma Biotechnology Initiates ALISCA-Lung2 Phase II Trial Armata Pharmaceuticals Highlights AP-SA02 Data at ISSSI 2026 Insmed Wins FDA Priority Review for ARIKAYCE sNDA Novo Nordisk Reports Positive Phase 3 CagriSema Resultsx Specialised Therapeutics Expands Opzelura Partnership in Australia Oracle Health Helps San Juan Regional Improve Patient Flow Grünenthal Acquires Stivarga Cancer Treatment From Bayer Concept Medical Presents SirPAD PAD Findings at VIVA 2026 Telix and ITM Announce $1.65B Radiopharmaceutical Merger Abbisko Therapeutics Reports Positive Phase 2 Lavengratinib Data Teva Study Examines Treatment Selection in Schizophrenia Teva Highlights New UZEDY Data in Schizophrenia Care Antengene Advances ATG-022 Into Phase III Gastric Cancer Study Kelun-Biotech to Present Sac-TMT Phase 3 Data at ESMO 2026 Teva Reports New TEV-749 Olanzapine LAI Clinical Data IntraBio Secures FDA Approval for AQNEURSA in A-T HFSA Highlights Late-Breaking Heart Failure Clinical Research CardiaCare Raises Seed Funding for Cardiac Clinical Studies Beactica Advances BEA-17 Toward Glioblastoma Trials